Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy-Reference-Cited by-同舟云学术

Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy

Published:2019-03-06 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Nishikawa Keiichi,Oishi Akio^ORCID,Hata Masayuki,Miyake Masahiro,Ooto Sotaro,Yamashiro Kenji^ORCID,Miyata Manabu^ORCID,Tamura Hiroshi^ORCID,Ueda-Arakawa Naoko,Takahashi Ayako,Kawashima Yu,Tsujikawa Akitaka

Funder

MEXT | Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-39995-5.pdf

Reference26 articles.

1. Congdon, N. et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122, 477–485 (2004).

2. Jager, R. D., Mieler, W. F. & Miller, J. W. Age-related macular degeneration. N Engl J Med 358, 2606–2617 (2008).

3. Singer, M. A. et al. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 119, 1175–1183 (2012).

4. Rofagha, S., Bhisitkul, R. B., Boyer, D. S., Sadda, S. R. & Zhang, K. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology 120, 2292–2299 (2013).

5. Maguire, M. G. et al. Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The comparison of age-related cmcular degeneration treatments trials. Ophthalmology 123, 1751–1761 (2016).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of Double-dose Aflibercept Treatment for Refractory Wet Age-related Macular Degeneration;Journal of the Korean Ophthalmological Society;2024-08-15

2. Seven-year outcome after 1-year fixed regimen of intravitreal aflibercept injections followed by pro re nata treatment for neovascular age-related macular degeneration;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-02-03

3. Aqueous Humor Cytokines Levels in Polypoidal Choroidal Vasculopathy before and after intravitreal injection of Conbercept;2022-08-25

4. Rescue photodynamic therapy for age-related macular degeneration refractory to anti-vascular endothelial growth factor monotherapy;Photodiagnosis and Photodynamic Therapy;2022-06

5. Soluble forms of cytokine and growth factor receptors: mechanisms of generation and modes of action in the regulation of local and systemic inflammation;FEBS Letters;2022-02-11